Pang et al. [163] |
AD |
hsa-let-7d, hsa-miR-144, hsa-miR-374a, and hsa-miR-106b targeting genes in pathways PI3K-AKT signaling pathway, MAPK signaling pathway, oxidative phosphorylation, synaptic vesicle cycle, cell–cell adhesion, cytokine-mediated signaling pathway, proteasome, arginine, proline metabolism and pentose phosphate pathway [163] |
Analysis of two important regions of the brain—entorhinal cortex (EC) and hippocampus (HIP) of AD patients revealed microRNAs that targeted genes in specific pathways |
Blood |
Multiple studies: Forero et al. [55, 59, 60, 164] |
MDD |
DEGs in various brain regions. MicroRNAs including hsa-miR-32, hsa-miR-33, hsa-miR-122, hsa-miR-429 associated with MDD. These microRNAs also known to regulate other MDD genes including GABA receptors, NOTCH2 and HNRNPU [60, 164]. Other miRNAs implicated include hsa-miR-370, hsa-miR-411, hsa-miR-433, hsa-miR-487b and hsa-miR-539 [165] |
Studies analyzed in the blood, amygdala, cerebellum, ACC and PFC regions revealed microRNAs linked to chronic stress and fear and GABA receptors linked to chronic stress and fear [55, 164] |
Various brain regions |
Wang et al. [166–168] |
SCZ |
hsa-miR409-3p [166–168] which targets genes associated with SCZ including FAM117B, GABRA1, GAD1, and NUMBL. hsa-miR-370 targets several SCZ associated genes including BDNF, NRG1 and SYN2 [166, 169]. Other microRNAs affected include miR-30e, miR-7, miR-195, miR-34a and miR-346 |
microRN As that targets genes associated with SCZ |
Tissue; blood; blood |
Multiple studies [61, 170] |
MDD and BD |
miR-652 [61, 170] |
microRNA affected in both MDD and BD |
Various sources (microRNA affected in both MDD and BD); blood |
Kohen et al. [63] |
SCZ, MDD and BD |
miR-182 |
RNA-seq revealed this microRNA was found activated in patients with BD and healthy controls while downregulated in MDD and SCZ [63] |
Brain tissue |
Multiple studies [61, 62] |
Multiple neuropsychiatric disorders |
miR-132, one of the microRNAs regulating expression of BDNF, and targets the genes MAOA and SLC6A3 |
One of the key players in brain plasticity and implicated in neuropsychiatric disorders [61, 62] |
Various sources (microRNA affected in both MDD and BD); various sources |
Srivastav et al. [171] |
ADHD |
microRNAs regulated the gene expression of BDNF, DAT1, HTR2C, HTR1B and SNAP-25 |
These microRNAs were also linked to ADHD etiology [171] |
Various sources |
Nakata et al. [64] |
ASD |
miR-6126 downregulated in ASD |
Study of microRNA expression in peripheral blood from adults with high functioning ASD compared with healthy controls |
Blood |
Gupta et al. [65] |
ADHD |
microRNAs associated with HPA axis regulation through FKBP5 were found to play a key role in PTSD |
Circulatory microRNAs to play an important role in PTSD |
Blood |
Martin et al. [172] |
PTSD |
Four upregulated microRNAs (miR-19a-3p, miR-101–3p, miR-20a-5p and miR-20b-5p) and four downregulated microRNAs (miR-15b-3p, miR-125b-5p, miR-128-3p and miR-486-3p) in PTSD samples |
Implications of microRNA dysregulation in PTSD patients |
Blood |